Ephedrine Sulfate patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10869845 ENDO VENTURES Ephedrine compositions and methods
Jan, 2040

(16 years from now)

Ephedrine Sulfate is owned by Endo Ventures.

Ephedrine Sulfate contains Ephedrine Sulfate.

Ephedrine Sulfate has a total of 1 drug patent out of which 0 drug patents have expired.

Ephedrine Sulfate was authorised for market use on 16 October, 2020.

Ephedrine Sulfate is available in solution;intravenous dosage forms.

The generics of Ephedrine Sulfate are possible to be released after 22 January, 2040.

Drugs and Companies using EPHEDRINE SULFATE ingredient

Market Authorisation Date: 16 October, 2020

Treatment: NA


How can I launch a generic of EPHEDRINE SULFATE before it's drug patent expiration?
More Information on Dosage

EPHEDRINE SULFATE family patents

Family Patents